- Home
- V vs LLY Comparison
V vs LLY Comparison
Compare V & LLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$330.48
HOLD
Current Price
$1,007.40
Company Overview
Basic Information| Metric | V | LLY |
|---|---|---|
| Founded | 1958 | 1876 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 619.8B | 948.5B |
| IPO Year | 2008 | N/A |
Fundamental Metrics
Financial Performance| Metric | V | LLY |
|---|---|---|
| Price | $330.48 | $1,007.40 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 23 | 18 |
| Target Price | $400.09 | ★ $1,063.44 |
| AVG Volume (30 Days) | ★ 6.4M | 3.9M |
| Earning Date | 10-28-2025 | 10-30-2025 |
| Dividend Yield | ★ 0.81% | 0.59% |
| EPS Growth | 4.85 | ★ 121.02 |
| EPS | 10.20 | ★ 20.44 |
| Revenue | $40,000,000,000.00 | ★ $59,419,800,000.00 |
| Revenue This Year | $13.34 | $42.59 |
| Revenue Next Year | $10.12 | $19.62 |
| P/E Ratio | ★ $32.47 | $49.42 |
| Revenue Growth | 11.34 | ★ 45.41 |
| 52 Week Low | $299.00 | $623.78 |
| 52 Week High | $375.51 | $1,111.99 |
Technical Indicators
Market Signals| Indicator | V | LLY |
|---|---|---|
| Relative Strength Index (RSI) | 45.66 | 53.32 |
| Support Level | $324.28 | $1,038.00 |
| Resistance Level | $336.06 | $1,111.99 |
| Average True Range (ATR) | 5.53 | 27.26 |
| MACD | 0.43 | -13.38 |
| Stochastic Oscillator | 69.10 | 8.00 |
Price Performance
Historical Comparison V
LLY
About V Visa Inc.
Visa is the largest payment processor in the world. In fiscal 2024, it processed almost $16 trillion in total volume. Visa operates in over 200 countries and processes transactions in over 160 currencies. Its systems are capable of processing over 65,000 transactions per second.
About LLY Eli Lilly and Company
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.